EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework

Paula Leão Moreira iD, Axel Dignass, Maria Manuela Estevinho iD, Francisco Portal, João Mendes, Mafalda Santiago, Walter Reinisch, Bruce E Sands, Geert D'Haens, Gerassimos J Mantzaris, Silvio Danese iD, Laurent Peyrin-Biroulet iD und 4 weitere

United European Gastroenterology Journal · 2024

DOI: 10.1002/ueg2.12679 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Paula Leão Moreira und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Unidade Local de Saúde São João, Porto, Portugal. Hauptthemen laut MEDLINE: Crohn Disease, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Longstanding disease control in Crohn's disease (CD) is challenging and requires understanding treatment efficacy and outcomes assessment. With multiple novel therapeutic options, rigorous evaluation of outcomes in randomized controlled trials (RCTs) is crucial to inform clinical practice. This study systematically reviewed RCTs focusing on CD outcomes to elucidate the breadth and depth of reported outcomes and measurement instruments. A systematic search was conducted on MEDLINE and Scopus for RCTs published from 1 January 2000 to 31 January 2023. Eligible studies included full‐text articles with at least 50 adult CD patients. Primary and secondary outcomes, along with their measurement instruments, were categorized according to the Outcome Measures in Rheumatology Filter 2.1 framework. From 88 included studies, 393 outcomes were analyzed. Clinical outcomes, such as clinical remission and response, were the most prevalent (50.6%); biomarkers (11.5%) and patient‐reported outcomes (10.2%) were also assessed. Other outcomes included disease behavior and complications (2%), endoscopy (10.4%), histology (0.5%), radiology (1.3%), healthcare utilization (3.8%), and therapy‐related safety (6.9%). Composite outcomes showed an increasing trend, reflecting a shift toward comprehensive evaluations. Coprimary endpoints, including clinical symptoms and mucosal inflammation, were reported in 21 of 88 studies. This review highlights the evolving landscape of outcome assessment in CD RCTs, emphasizing the increasing complexity of outcomes. The prominence of composite outcomes underscores efforts to capture the multidimensional nature of CD. These findings will inform the second stage of a two‐round e‐Delphi aimed at prioritizing key domains and outcomes for developing a multiple‐component outcome for RCTs in CD research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseRandomized Controlled Trials as TopicHumansTreatment OutcomePatient Reported Outcome MeasuresRemission InductionOutcome Assessment, Health CareBiomarkers

Stichwörter der Autor:innen

Crohn diseasePROsRCTcompositeendpointsmeasurementremissionresponsetherapytreatment efficacy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Unidade Local de Saúde São João, Porto, Portugal.
  • Department of Medicine I, Agaplesion Markus Hospital, Goethe University, Frankfurt/Main, Germany.
  • Department of Gastroenterology, Unidade Local de Saúde Gaia Espinho, Vila Nova de Gaia, Portugal.
  • Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal.
  • GEDII-Portuguese Inflammatory Bowel Disease Study Group, Porto, Portugal.
  • Department of Internal Medicine III, Division Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Paula Leão Moreira, Maria Manuela Estevinho, Silvio Danese, Laurent Peyrin-Biroulet

Zitieren

APA

Moreira, P. L., Dignass, A., Estevinho, M. M., Portal, F., Mendes, J., Santiago, M., Reinisch, W., Sands, B. E., D'Haens, G., Mantzaris, G. J., Danese, S., Peyrin-Biroulet, L., Jairath, V., Dotan, I., Magro, F., & International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) (2024). Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12679

Vancouver

Moreira PL, Dignass A, Estevinho MM, Portal F, Mendes J, Santiago M, et al. Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12679

BibTeX
@article{Moreira2024,
  author = {Moreira, Paula Leão and Dignass, Axel and Estevinho, Maria Manuela and Portal, Francisco and Mendes, João and Santiago, Mafalda and Reinisch, Walter and Sands, Bruce E and D'Haens, Geert and Mantzaris, Gerassimos J and Danese, Silvio and Peyrin-Biroulet, Laurent and Jairath, Vipul and Dotan, Iris and Magro, Fernando and International Organization for the Study of Inflammatory Bowel Diseases (IOIBD), International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)},
  title = {Assessment of outcomes in Crohn's disease: A systematic review of randomized clinical trials to inform a multiple outcome framework},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  doi = {10.1002/ueg2.12679}
}
Kostenlos starten →